Transjugular intrahepatic portosystemic shunt

Changed by Ian Bickle, 11 May 2016

Updates to Article Attributes

Body was changed:

A transjugular intrahepatic portosystemic shunt (TIPS) is a treatment for portal hypertension in which a direct communication is formed between a hepatic vein and a branch of the portal vein, thus bypassing the liver. A successful endpoint is a portosystemic gradient of <12 mmHg.

Indications

Many patients have end stage liver disease. Indications include

Relative contraindications
  • severeright heart failure
  • cavernous transformation of the portal vein
  • severe rapidly progressive hepatic progressive hepatic failure
  • multi-cystic hepatic disease
  • severe hepatic encephalopathy
  • main portal vein occlusion
  • polycystic kidney disease
  • hypervascular hepatic tumour

Complications

  • blockage: TIPS occlusion. A portovenogram with re-stenting is indicated when there is recurrent bleeding and decreased doppler flow on follow up.
  • uncontrollable hepatic encephalopathy
  • hepatic venous stenosis
  • haemorrhage (haemoperitoneum, intrahepatic haematoma, subcapsular haematoma
  • sepsis secondary to infection 6
  • unintentional arterial access 7,8
Methods to assess patency
  • colour Doppler1
  • CT angiography 4
  • portography with portal manometry

See: TIPS evaluation

Factors affecting poor survival 5
  • hyponatremia
  • hyperbilirubinemia
  • elevated serum ALT
  • advanced liver disease
  • coexisting renal insufficiency

See also

  • -<p>A <strong>transjugular intrahepatic portosystemic shunt (TIPS)</strong> is a treatment for <a href="/articles/portal-hypertension">portal hypertension</a> in which a direct communication is formed between a hepatic vein and a branch of the <a href="/articles/portal-vein">portal vein</a>, thus bypassing the <a href="/articles/couinaud-classification">liver</a>. A successful endpoint is a portosystemic gradient of &lt;12 mmHg. </p><h5>Indications</h5><p>Many patients have end stage liver disease. Indications include</p><ul>
  • +<p>A <strong>transjugular intrahepatic portosystemic shunt (TIPS)</strong> is a treatment for <a href="/articles/portal-hypertension">portal hypertension</a> in which a direct communication is formed between a hepatic vein and a branch of the <a href="/articles/portal-vein">portal vein</a>, thus bypassing the <a href="/articles/couinaud-classification">liver</a>. A successful endpoint is a portosystemic gradient of &lt;12 mmHg.</p><h5>Indications</h5><p>Many patients have end stage liver disease. Indications include</p><ul>
  • -<li>variceal bleeding (for treatment in acute setting <sup>5</sup>)</li>
  • +<li>variceal bleeding (for treatment in acute setting <sup>5</sup>)</li>
  • -<li><a href="/articles/portal-hypertensive-gastropathy-enteropathy-colopathy">portal hypertensive gastropathy</a></li>
  • +<li><a href="/articles/portal-hypertensive-gastropathy-enteropathy-colopathy">portal hypertensive gastropathy</a></li>
  • -<li>severe <a href="/articles/right-heart-failure">right heart failure</a>
  • +<li>severe <a href="/articles/right-heart-failure">right heart failure</a>
  • -<li>severe rapidly progressive hepatic failure</li>
  • +<li>severe rapidly progressive hepatic failure</li>
  • -<li>severe hepatic encephalopathy </li>
  • +<li>severe hepatic encephalopathy</li>
  • -<li>blockage: <a href="/articles/tips-occlusion">TIPS occlusion</a>. A portovenogram with re-stenting is indicated when there is recurrent bleeding and decreased doppler flow on follow up. </li>
  • +<li>blockage: <a href="/articles/tips-occlusion">TIPS occlusion</a>. A portovenogram with re-stenting is indicated when there is recurrent bleeding and decreased doppler flow on follow up.</li>
  • -<li>colour Doppler <sup>1</sup>
  • +<li>colour Doppler <sup>1</sup>
Images Changes:

Image 7 DSA (angiography) (TIPS) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.